Clinical Trials Browser

Phase 3 × Omeprazole × 1 year × Clear all

NCT05646862 2026-02-05

INAVO121

Phase 3 Active not recruiting

Breast Neoplasms

NCT05680870 2025-09-09

The Possible Protective Role of Omeprazole Against Oxaliplatin Induced Neuropathy in Cancer Patients

Phase 3 Completed

Gastrointestinal

Pancreatic Neoplasms, Peripheral Nervous System Diseases, Colorectal Neoplasms

NCT07016737 2025-06-12

ESO-Nanjing12

Phase 3 Enrolling by invitation

Gastrointestinal

Esophageal Squamous Cell Carcinoma